AzTrials
AzTrials

Asthma ChildhoodQigong-PedAsthNCT07883967

Effects of Tele-rehabilitation-Guided Qigong on Children and Adolescents With Asthma

A study testing Tele-rehabilitation-guided Qigong in people with Asthma Childhood, run by Antalya Health Sciences University at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study investigates the effects of a tele-rehabilitation-guided Qigong exercise program on pulmonary function, functional exercise capacity, and symptom control in children and adolescents with mild-to-moderate asthma. Read more about this study

Who is it for?
Ages 8 to 17 years
Conditions the study is for
Asthma Childhood
What is being tested?
Tele-rehabilitation-guided Qigong
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Oct 2026to 30 Aug 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Physician-confirmed diagnosis of asthma according to international guidelines (e.g., GINA criteria) for at least 6 months.
  • Age between 8 and 18 years at the time of enrollment.
  • Clinically stable asthma with no severe exacerbation or change in maintenance controller therapy in the past 4 weeks.
  • Ability to perform standard spirometry and functional exercise tests.
  • Access to an internet-connected device (smartphone, tablet, or computer) suitable for tele-rehabilitation video sessions.
  • Signed written informed consent by parent/legal guardian and assent by the child/adolescent.

Who cannot join

  • Diagnosis of other chronic lung diseases (e.g., cystic fibrosis, bronchiectasis, primary ciliary dyskinesia).
  • Significant musculoskeletal, cardiovascular, or neurological disorders that impair the ability to perform physical exercise.
  • Recent systemic corticosteroid use or hospitalization due to an acute asthma exacerbation within the last 4 weeks.
  • Regular participation in structured mind-body practices (such as Qigong, Tai Chi, or Yoga) within the past 3 months.
  • Inability to comply with the study protocol or follow tele-rehabilitation instructions.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Güney Küçük Külice, M.D. contact

+90 242 249 44 00

guneykucuk07@gmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Antalya Training and Research Hospital, University of Health Sciences

    Antalya, Antalya, 07100

    Güney Küçük Külice, MD, +90 242 249 44 00, guneykucuk07@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: The Effects of a Tele-rehabilitation-Guided Qigong Exercise Program on Pulmonary Function, Functional Capacity, and Symptom Control in Children and Adolescents With Asthma: A Randomized Controlled Trial

This study investigates the effects of a tele-rehabilitation-guided Qigong exercise program on pulmonary function, functional exercise capacity, and symptom control in children and adolescents with mild-to-moderate asthma.

Participants aged 8 to 18 years will be randomly assigned to either an intervention group or a control group. The intervention group will participate in an 8-week, home-based, tele-rehabilitation-supervised Qigong exercise program in addition to standard medical care. The control group will continue receiving standard medical treatment and routine follow-up.

The primary aim of the study is to evaluate changes in pulmonary function (spirometric parameters such as FEV1 and FVC) and functional exercise capacity measured by the 6-Minute Walk Test (6MWT). Secondary outcomes include asthma symptom control assessed via the Asthma Control Test (ACT/c-ACT) and health-related quality of life.

Read the detailed description

Pediatric asthma is a prevalent chronic inflammatory airway disease associated with significant morbidity, impaired functional exercise tolerance, and reduced quality of life. While pharmacotherapy represents the cornerstone of management, complementary non-pharmacological interventions, including mind-body exercises, are increasingly recognized for their potential benefits in improving respiratory mechanics and symptom control.

This single-center, randomized controlled clinical trial evaluates the feasibility and therapeutic efficacy of an 8-week tele-rehabilitation-delivered Qigong program in pediatric patients diagnosed with asthma according to GINA guidelines.

Eligible participants will be randomized in a 1:1 ratio into two groups:

  1. Intervention Group: Participants will undergo supervised online group Qigong sessions led by experienced rehabilitation specialists, complemented by structured home-practice routines, alongside routine asthma medical maintenance.
  2. Control Group: Participants will maintain standard asthma pharmacological therapy with conventional clinical follow-up without structured exercise intervention.

Baseline and post-intervention assessments (at week 8) will include spirometry (FEV1, FVC, FEV1/FVC ratio, FEF25-75), functional exercise tolerance evaluated using the standardized 6-Minute Walk Test (6MWT), asthma control level assessed using the Asthma Control Test (ACT) or Childhood Asthma Control Test (c-ACT), and pediatric health-related quality of life scores. Adherence, safety, and adverse events will be monitored throughout the study period.

Being tested
Tele-rehabilitation-guided Qigong
Keywords
qigong, Telerehabilitation, Mind-Body Therapies, Exercise Therapy, Pediatric Asthma, Pulmonary Function

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Tele-rehabilitation-guided QigongBehavioural

    An 8-week home-based Qigong exercise program delivered and supervised via tele-rehabilitation sessions in addition to standard medical asthma care.

Study groups in NCT07883967
Study groupRoleWhat they receive
Intervention GroupExperimentalParticipants receive an 8-week tele-rehabilitation-supervised Qigong exercise program in addition to standard medical asthma care.
Receives: Behavioral: Tele-rehabilitation-guided Qigong
Control GroupNo interventionParticipants receive standard medical asthma care and routine clinical follow-up without any structured exercise program.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from Baseline in Forced Expiratory Volume in 1 Second (FEV1)

    Assessed by standard spirometry. FEV1 will be measured in liters and reported as percent of predicted value according to international pediatric respiratory guidelines.

    Measured: Baseline and Week 8

  2. Change from Baseline in 6-Minute Walk Distance (6MWD)

    Functional exercise capacity evaluated by the standardized 6-Minute Walk Test (6MWT), measuring the total distance walked in meters in 6 minutes.

    Measured: Baseline and Week 8

Secondary outcomes (3)
  1. Change from Baseline in 6-Minute Walk Distance (6MWD)

    Assessed using the standardized 6-Minute Walk Test (6MWT). Total distance walked in meters within 6 minutes will be recorded to evaluate functional exercise capacity.

    Measured: Baseline and Week 8

  2. Change from Baseline in Asthma Control Test (ACT) Score

    Assessed using the Asthma Control Test (ACT) for adolescents (≥12 years) or Childhood Asthma Control Test (c-ACT) for children (<12 years). Higher scores indicate better symptom control.

    Measured: Baseline and Week 8

  3. Change from Baseline in Pediatric Asthma Quality of Life Questionnaire (PAQLQ) Score

    Assessed via the standardized Pediatric Asthma Quality of Life Questionnaire. Evaluates physical activity limitation, symptoms, and emotional function related to asthma.

    Measured: Baseline and Week 8

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Oct 2026
  2. Study start15 Oct 2026
  3. Primary completion30 May 2027 (estimated)
  4. Study completion30 Aug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07883967
Sponsor's protocol ID
16/4
Acronym
Qigong-PedAsth
Status last verified
Oct 2026
First submitted
14 Oct 2026
Last updated
29 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Individual participant data will not be broadly shared to protect participant confidentiality and privacy in accordance with local institutional ethics regulations and national personal data protection laws. De-identified study data and summary results may be shared upon reasonable request to the corresponding author for valid scientific inquiries.

Questions about this trial

What is this clinical trial studying?

A study testing Tele-rehabilitation-guided Qigong in people with Asthma Childhood, run by Antalya Health Sciences University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 29 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Güney Küçük Külice, M.D. (+90 242 249 44 00, guneykucuk07@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from Baseline in Forced Expiratory Volume in 1 Second (FEV1) (time frame: Baseline and Week 8). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in